Pentraxin‐3 Plasma Levels Correlate With Tumour Burden and Overall Survival in Patients With Primary Myelofibrosis

In a recent study, researchers found high pentraxin-3 (PTX3) plasma levels in the bone marrow of patients with primary myelofibrosis, compared with healthy participants, suggesting a correlation between PTX3 plasma levels and disease burden and overall survival.

 British Journal of Haematology

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.